Your browser doesn't support javascript.
loading
Breast conservative surgery and whole breast radiotherapy versus breast conservative surgery and IORT: surgical opinion.
Invento, Alessandra; Mirandola, Sara; Deguidi, Giulia; Cernusco, Luna; Mazzarotto, Renzo; Pellini, Francesca.
Afiliação
  • Invento A; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy - alessandra.invento@ieo.it.
  • Mirandola S; Unit of Breast Surgery, Ospedale Civile Maggiore, University Hospital of Verona, Verona, Italy.
  • Deguidi G; Unit of Breast Surgery, Ospedale Civile Maggiore, University Hospital of Verona, Verona, Italy.
  • Cernusco L; Unit of Radiotherapy, Ospedale Civile Maggiore, University Hospital of Verona, Verona, Italy.
  • Mazzarotto R; Unit of Radiotherapy, Ospedale Civile Maggiore, University Hospital of Verona, Verona, Italy.
  • Pellini F; Unit of Breast Surgery, Ospedale Civile Maggiore, University Hospital of Verona, Verona, Italy.
Minerva Surg ; 77(2): 95-100, 2022 Apr.
Article em En | MEDLINE | ID: mdl-34338456
ABSTRACT

BACKGROUND:

To define the possibility of intraoperative radiation therapy (IORT)'s application on clinical practice and point out the problems observed by Verona Breast Unit.

METHODS:

Among the patients of the Breast Unit at Azienda Ospedaliera Universitaria Integrata of Verona, treated between July 2015 and June 2017, were identified 459 patients undergoing breast conserving surgery for a carcinoma, followed by IORT in 77 cases or by Whole Breast Radiotherapy (WBRT) in 382 cases. The data of WBRT group were analyzed considering IORT eligibility criteria to identify a sub-group of eligible patients, for whom we evaluated the diagnostic process that had led to exclusion from IORT.

RESULTS:

In WBRT group 184 patients (48%) had a ductal NOS infiltrating carcinoma, of which 64 cases (16.8%) were eligible for IORT. Other 79 patients of WBRT group (21%) presented DCIS, of which only 27 were in the American Society for Radiation Oncology "suitable" group for IORT. Considering the results of the preoperative exams, or rather needle biopsy and MRI scan, 55 patients of 64 (85.9%) resulted unsuitable for IORT, while nine patients (14.1%) could be eligible.

CONCLUSIONS:

IORT's major limits are the restricted eligibility criteria, especially on histology; the need of a complete execution of preoperative exams and the technical limits of these exams. ASTRO suitable group, including small diameter, low-grade DCIS, might be used to extend the eligibility criteria. A multidisciplinary approach might improve the preoperative study, so the use of IORT in clinical practice.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Intraductal não Infiltrante / Radioterapia (Especialidade) Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Intraductal não Infiltrante / Radioterapia (Especialidade) Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article